22.418 makale bulundu

Giriş cümleleri: Catechol-O-metiltransferaz inhibisyonu - Parkinson hastalığında L-dopa tedavisini çift enzim inhibisyonu ile geliştirmek için yenilikçi bir yaklaşım.

Introductory remarks: Catechol-O-methyltransferase inhibition--an innovative approach to enhance L-dopa therapy in Parkinson's disease with dual enzyme inhibition.

Nissinen E.

Int Rev Neurobiol · 2010-01-01

DOI: 10.1016/b978-0-12-381326-8.00001-6PMID: 21095456

NR2B seçici antagonistlerinin yapı-aktivite ilişkileri ve CNS terapötik uygulamalarına bakış.

Insights into structure-activity relationships and CNS therapeutic applications of NR2B selective antagonists.

Beinat C, Banister S, Moussa I, Reynolds AJ, McErlean CS, Kassiou M.

Curr Med Chem · 2010-01-01

DOI: 10.2174/092986710793348572PMID: 20939817

Ekstrapiramidal bozukluklarda disotonomun tedavisi.

Treatment of dysautonomia in extrapyramidal disorders.

Ziemssen T, Reichmann H.

Ther Adv Neurol Disord · 2010-01-01

DOI: 10.1177/1756285609348902PMID: 21180636

Fibroblastlar tarafından aşırı nöronal aktivitenin modülasyonu: Parkinson hastalığının tedavisinde potansiyel kullanım.

Modulation of excessive neuronal activity by fibroblasts: potential use in treatment of Parkinson's disease.

Finberg JP, Gluzman Z, Reshef M, Loboda Y, Mohsen U, Bressler-Stramer T, Miari R, Gepstein L, Marom S, Feld Y.

Restor Neurol Neurosci · 2010-01-01

DOI: 10.3233/rnn-2010-0551PMID: 21209495

[Parkinson hastalığının geç evrelerinde motor tezahürlerin farmakoterapisi].

[Pharmacotherapy of motor manifestations in late stages of Parkinson's disease].

Bogdanov RR, Kotov SV, Kunitsyna AN, Turbina LG.

Zh Nevrol Psikhiatr Im S S Korsakova · 2010-01-01

PMID: 21183918

Kök hücreler: Tıbbi terapötiklerde yeni bir paradigma.

Stem cells: a new paradigm in medical therapeutics.

Mankikar SD.

J Long Term Eff Med Implants · 2010-01-01

DOI: 10.1615/jlongtermeffmedimplants.v20.i3.50PMID: 21395520

Kronik düşük doz rotenon tedavisinin insan mikroglial hücreleri üzerindeki etkileri.

Effects of chronic low dose rotenone treatment on human microglial cells.

Shaikh SB, Nicholson LF.

Mol Neurodegener · 2009-12-31

DOI: 10.1186/1750-1326-4-55PMID: 20042120

Parkinson hastalığı olan bir hastada ekstramammary Paget'in aksilla hastalığı için başarılı intra-arteriyel kemoterapi.

Successful intra-arterial chemotherapy for extramammary Paget's disease of the axilla in a patient with Parkinson's disease.

Damascelli B, Ticha V.

Cardiovasc Intervent Radiol · 2009-12-31

DOI: 10.1007/s00270-009-9786-1PMID: 20043224

BENZOARYLUREIDO KOMPOUNDLAR VE DE ⁇ ERLENDİRME VE TEDAVİ NEURODEGENERATİF BEYİN HASTALIKLARI İÇİN KOMPOZİYON

BENZOARYLUREIDO COMPOUNDS, AND COMPOSITION FOR PREVENTION OR TREATMENT OF NEURODEGENERATIVE BRAIN DISEASE CONTAINING THE SAME

HAHN HOH-GYU, NAM KEE-DAL, SHIN DONG-YUN, PARK CHAN-HO, CHO SUNG-WOO, KIM EUN-A, NAM GHIL-SOO, CHOI KYUNG-IL, SEO SEON-HEE, SHIN HEE-SUP, KIM DONG-JIN, PAE AE-NIM, CHUNG HYE-JIN, CHOO HYUN-AH, RHIM HYE-WHON, CHO YONG-SEO, ROH EUN-JOO, KEUM GYO-CHANG, CHOI KEE-HYUN, SHIN KYE-JUNG, CHEONG CHAN-SEONG, LEE JAE-KYUN, KANG YONG-KOO, KIM YOUNG-SOO, PARK WOONG-SEO, KIM KEY-SUN, CHUNG HE-SSON, SONG CHI-MAN, MIN SUN-JOON, KIM EUNICE EUN-KYEONG, LEE CHEOL-JU, KANG SOON-BANG.

· 2009-12-29

BENZOARYLUREIDO KOMPOUNDLAR VE DE ⁇ ERLENDİRME VE TEDAVİ NEURODEGENERATİF BEYİN HASTALIKLARI İÇİN KOMPOZİYON

BENZOARYLUREIDO COMPOUNDS, AND COMPOSITION FOR PREVENTION OR TREATMENT OF NEURODEGENERATIVE BRAIN DISEASE CONTAINING THE SAME

HAHN HOH-GYU, NAM KEE-DAL, SHIN DONG-YUN, PARK CHAN-HO, CHO SUNG-WOO, KIM EUN-A, NAM GHIL-SOO, CHOL KYUNG-IL, SEO SEON-HEE, SHIN HEE-SUP, KIM DONG-JIN, PAE AE-NIM, CHUNG HYE-JIN, CHOO HYUN-AH, RHIM HYE-WHON, CHO YONG-SEO, ROH EUN-JON, KEUM GYO-CHANG, CHOI KEE-HYUN, SHIN KYE-JUNG, CHEONG CHAN-SEONG, LEE JAE-KYUN, KANG YONG-KOO, KIM YOUNG-SOO, PARK WOONG-SEO, KIM KEY-SUN, CHUNG HE-SSON, SONG CHI-MAN, MIN SUN-JOON, KIM EUNLCE EUN-KYEONG, LEE CHEOL-JU, KANG SOON-BANG.

· 2009-12-29

Metabotropik glutamat reseptörü tip 5 levodopa kaynaklı motor komplikasyonlarda.

Metabotropic glutamate receptor type 5 in levodopa-induced motor complications.

Ouattara B, Grégoire L, Morissette M, Gasparini F, Vranesic I, Bilbe G, Johns DR, Rajput A, Hornykiewicz O, Rajput AH, Gomez-Mancilla B, Di Paolo T.

Neurobiol Aging · 2009-12-29

DOI: 10.1016/j.neurobiolaging.2009.07.014PMID: 20036444

Levodopa ile tedavi edilen Parkinson hastalarında hiperhomosisteinemi tekrarı.

Hyperhomocysteinemia recurrence in levodopa-treated Parkinson's disease patients.

Belcastro V, Pierguidi L, Castrioto A, Menichetti C, Gorgone G, Ientile R, Pisani F, Rossi A, Calabresi P, Tambasco N.

Eur J Neurol · 2009-12-27

DOI: 10.1111/j.1468-1331.2009.02894.xPMID: 20050890